Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price reached a new 52-week low on Thursday . The stock traded as low as GBX 1.60 ($0.02) and last traded at GBX 1.68 ($0.02), with a volume of 1275106 shares trading hands. The stock had previously closed at GBX 1.65 ($0.02).
Cizzle Biotechnology Stock Performance
The firm has a market cap of £6.64 million, a P/E ratio of 168.00 and a beta of 0.35. The company has a 50 day moving average of GBX 2 and a 200 day moving average of GBX 2.12.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
See Also
- Five stocks we like better than Cizzle Biotechnology
- What does consumer price index measure?
- Meta Stock: 3 Reasons This Stumble Is a Golden Buying Opportunity
- The How And Why of Investing in Oil Stocks
- 3 Staples Stocks to Cushion Lower Consumer Sentiment
- Are Penny Stocks a Good Fit for Your Portfolio?
- Zillow’s Earnings Dip: An Opportunity for Visionaries
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
